The company’s portfolio totals
200+ pharmaceuticals
The company’s portfolio totals
200+ pharmaceuticals
Our products
ЛPeople caring for people
People caring for people
Akrikhin produces a wide range
of socially important pharmaceuticals,
including those under the INN-Akrikhin brand
Akrikhin produces a wide range
of socially important pharmaceuticals,
including those under the INN-Akrikhin brand
Learn more
Akrikhin today
45 %
of our pharmaceuticals
are classified as vital and essential drugs
are classified as vital and essential drugs
Our expertise
Key therapeutic areas
01 — Dermatology
02 — Cardiology
03 — Vitamin D
04 — Endocrinology
05 — Neurology
06 — Paediatrics
07 — Cosmetology
Dermatology
Cardiology
Vitamin D
Endocrinology
Neurology
Paediatrics
Cosmetology
Dermatology
Cardiology
Vitamin D
Endocrinology
Neurology
Paediatrics
Cosmetology
We
invest
in the development of new medicines
We invest
in the development of new medicines
First generics, new dosage forms of existing medicines, development of new combinations
Own
R&D Center
R&D Center
Research
Activities
Activities
50+
medicines under active development
We launch
10+ medicines
every year
10+ medicines
every year
High quality standards
All our products are manufactured in strict compliance with international GMP standards at every stage of the development, production and storage of medicines
All our products are manufactured in strict compliance with international GMP standards at every stage of the development, production and storage of medicines
GMP
Modern manufacturing complex
We produce effective, affordable, and high-quality pharmaceuticals
We produce effective, affordable, and high-quality pharmaceuticals
Contract manufacturing
The long-term expertise, adherence to international GMP standards and high professionalism of our employees make the company an attractive partner in the field of contract manufacturing
Cooperate with us
Company news
Company news
Stay up-to-date with Akrikhin's latest news, events and announcements.
Stay up-to-date with Akrikhin's latest news, events and announcements.
Press Center